Big Move For Oruka Therapeutics, Inc.
Tue, Sep 10, 2024 at 05:30 PM
Oruka Therapeutics, Inc. (ABIO:NASDAQ) shot up at $28.8, representing a gain of 1052%. On Mon, Sep 09, 2024, ABIO:NASDAQ hit a New 6-Month Intraday Low of $2.25. The stock got featured on our News Catalysts scanner on Tue, Sep 03, 2024 at 08:50 AM in the 'MERGER' category. From Mon, Aug 26, 2024, the stock recorded 11.11% Up Days and 80.00% Green Days
About Oruka Therapeutics, Inc. (ABIO:NASDAQ)
ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.
Top 10 Gainers:
- Hempacco Co. Inc. (HPCO:NASDAQ), 1342.86%
- Oruka Therapeutics, Inc. (ABIO:NASDAQ), 1052%
- Quhuo Limited (QH:NASDAQ), 306.6%
- iLearningEngines Holdings Inc Cl A (AILE:NASDAQ), 115.11%
- BIO-key International, Inc. (BKYI:NASDAQ), 92.31%
- Trevena, Inc. (TRVN:NASDAQ), 53.73%
- FibroBiologics Inc. (FBLG:NASDAQ), 49.62%
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 47.53%
- PAVmed Inc. (PAVM:NASDAQ), 43.7%
- LightInTheBox Holding Co., Ltd. (LITB:NYSE), 41.18%